Evolving Concepts in Dilated Cardiomyopathy

Эволюция представлений о дилатационной кардиомиопатии
Marco Merlo, Antonio Nicola Cannata, Marco Gobbo, Davide Stolfo, Perry M Elliot, Gianfranco Sinagra
2017-12-22

Arrhythmic risk stratificationCardiac magnetic resonanceDilated cardiomyopathyGenetic cardiomyopathySystolic heart failure
Dilated cardiomyopathy (DCM) represents a particular aetiology of systolic heart failure that frequently has a genetic background and usually affects young patients with few co-morbidities. The prognosis of DCM has improved substantially during the last decades due to more accurate aetiological characterization, the red-flag integrated approach to the disease, early diagnosis through systematic familial screening, and the concept of DCM as a dynamic disease requiring constant optimization of medical and non-pharmacological evidence-based treatments. However, some important issues in clinical management remain unresolved, including the role of cardiac magnetic resonance for diagnosis and risk categorization and the interaction between genotype and clinical phenotype, and arrhythmic risk stratification. This review offers a comprehensive survey of these and other emerging issues in the clinical management of DCM, providing where possible practical recommendations.
1
DCM is increasingly understood as a dynamic disease requiring ongoing adjustment of medical and non-pharmacological treatments.
2
DCM prognosis has substantially improved through precise etiological characterization, integrated red-flag assessment, systematic familial screening, and continuously optimized evidence-based therapy.
3
Dilated cardiomyopathy is a form of systolic heart failure that frequently has a genetic basis and typically affects young patients with few comorbidities.
4
Important management questions remain unresolved regarding cardiac magnetic resonance for diagnosis and risk categorization, genotype–phenotype interactions, and arrhythmic-risk stratification.
5
The review surveys emerging clinical-management issues in DCM and provides practical recommendations where evidence permits.

dilated cardiomyopathy (DCM)

clinical management, diagnosis, prognosis, and arrhythmic risk stratification of DCM, including genotype–phenotype interactions

Publication Details
Publication Date
2017-12-22
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Marco Merlo
Antonio Nicola Cannata
Marco Gobbo
Davide Stolfo
Perry M Elliot
Gianfranco Sinagra
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%